Click to view your profile
Click to search for condition or expert
Click to open main menu
Prurigo Nodularis Latest Advances
Find the Latest Research About Prurigo Nodularis
Save
Bookmark
Share
Share
Overview
Find a Doctor
Latest Advances
Clinical Trials
Treatments
Customize your search results with filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 02/19/2023
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
See more filters
Nemolizumab: An Innovative Biologic Treatment to Control Interleukin 31, a Key Mediator in Atopic Dermatitis and Prurigo Nodularis.
Condition:
Atopic Dermatitis and Prurigo Nodularis
Journal:
Actas dermo-sifiliograficas
Treatment Used:
Nemolizumab
Number of Patients:
0
Published:
July 16, 2022
VIEW PUBLICATION
Nemolizumab efficacy in prurigo nodularis: onset of action on itch and sleep disturbances.
Condition:
Prurigo Nodularis (PN)
Journal:
Journal of the European Academy of Dermatology and Venereology : JEADV
Treatment Used:
Nemolizumab
Number of Patients:
70
Published:
June 29, 2022
VIEW PUBLICATION
Non-Atopic Chronic Nodular Prurigo (Prurigo Nodularis Hyde): A Systematic Review of Best-Evidenced Treatment Options.
Condition:
Non-Atopic Chronic Nodular Prurigo (CNPG)
Journal:
Dermatology (Basel, Switzerland)
Treatment Used:
Targeted Therapies
Number of Patients:
0
Published:
April 13, 2022
VIEW PUBLICATION
Cognitive Impairment in Inpatients with Prurigo Nodularis and Psychiatric Comorbidities.
Journal:
International journal of environmental research and public health
Published:
July 02, 2021
VIEW PUBLICATION
High-Potency Topical Steroid Treatment of Multiple Keratoacanthomas Associated With Prurigo Nodularis.
Journal:
Cutis
Published:
June 07, 2021
VIEW PUBLICATION
Dupilumab in prurigo nodularis: a systematic review of current evidence and analysis of predictive factors to response.
Condition:
Prurigo Nodularis (PN)
Journal:
The Journal of dermatological treatment
Treatment Used:
Dupilumab
Number of Patients:
45
Published:
November 17, 2020
VIEW PUBLICATION
THREE CASES OF ATOPIC DERMATITIS CHILDREN WITH INTRACTABLE PRURIGO NODULARIS.
Condition:
Atopic Dermatitis with Intractable Prurigo Nodularis
Journal:
Arerugi = [Allergy]
Treatment Used:
Cyclosporine A (CyA) and Duplimab
Number of Patients:
3
Published:
May 22, 2020
VIEW PUBLICATION
Dupilumab improves clinical manifestations, symptoms, and quality of life in adult patients with chronic nodular prurigo.
Condition:
Chronic Nodular Prurigo
Journal:
Journal of the American Academy of Dermatology
Treatment Used:
Dupilumab
Number of Patients:
27
Published:
April 02, 2020
VIEW PUBLICATION
Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis.
Condition:
Prurigo Nodularis
Journal:
The New England journal of medicine
Treatment Used:
Nemolizumab
Number of Patients:
70
Published:
February 20, 2020
VIEW PUBLICATION
Dupilumab for prurigo nodularis: Case series and review of the literature.
Condition:
Prurigo nodularis
Journal:
Dermatologic therapy
Treatment Used:
Dupilumab
Number of Patients:
11
Published:
January 10, 2020
VIEW PUBLICATION
Dupilumab Treatment for Prurigo Nodularis and Pruritis
Condition:
Prurigo Nodularis and Pruritis
Journal:
Journal of drugs in dermatology : JDD
Treatment Used:
Dupilumab
Number of Patients:
0
Published:
September 17, 2019
VIEW PUBLICATION
An observational analysis of low-dose thalidomide in recalcitrant prurigo nodularis.
Condition:
Recalcitrant prurigo nodularis
Journal:
Clinical and experimental dermatology
Treatment Used:
Low-dose thalidomide
Number of Patients:
17
Published:
May 28, 2019
VIEW PUBLICATION
Showing 1-12 of 15
Next
Last Updated: 02/19/2023